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Objective: A systematic review, meta-analysis and meta-regression were performed on 
selected studies to investigate the incidence of atrial fibrillation (AF) amongst athletes 
compared to non-athlete controls.  
 
Design: Meta-analysis with heterogeneity analysis and subsequent meta-regression to model 
covariates were performed. The mode of exercise (endurance and mixed sports) and age were 
the a priori determined covariates. 
 
Data sources: PubMed, MEDLINE, Science Direct, SPORTDiscus and the Cochrane library 
were searched. 
 
Eligibility criteria: Research articles published after 1990 and before 2nd December 2020 
were included if they reported the number of AF cases in athletes with non-athlete 
(physically active or inactive) control groups, were case-control or cohort studies and if data 
allowed calculation of odds ratios (OR). 
  
Results: The risk of developing AF was significantly higher in athletes than in non-athlete 
controls (OR: 2.46; 95% CI 1.73-3.51; p<0.001, Z=4.97). Mode of exercise and risk of AF 
were moderately correlated (B=0.1259, p=0.0193), with mixed sport conferring a greater risk 
of AF than endurance sport (B=-0.5476, p=0.0204). Younger (<55 yrs) athletes were 
significantly more likely to develop AF compared to older (55 yrs) athletes (B =-0.02293, 
p<0.001). 
 
Conclusion: Athletes have a significantly greater likelihood of developing AF compared to 
non-athlete controls; with those participating in mixed sport and younger athletes at the 
greatest risk. Future studies of AF prevalence in athletes according to specific exercise dose 








Physical activity and exercise training reduce metabolic disease risk,1 improve cardiovascular 
health2 and mental wellbeing,3 and are associated with healthy aging.4 Studies also suggest 
that exercise can reduce the burden of arrhythmias, such as atrial fibrilliation (AF)5 6, which 
is the most common cardiac arrhythmia worldwide. Indeed, the prevalence of AF in the 
general population is as high as 3.3%7 and is associated with a 1.5-fold increased mortality 
risk, most commonly secondary to cerebrovascular events.8  
 
AF is also the most prevalent arrhythmia in athletic populations. It has been reported that 
male endurance athletes performing high-intensity and high-volume exercise training are at 
an increased risk,9 with studies suggesting a U-shaped curve, with lack of physical activity 
and long-term vigourous exercise both increasing the risk of developing AF.10 11 The 
mechanisms by which exercise training increases the risk of AF are complex and 
speculative,12 but may include atrial dilation, adrenergic activation, vagal tone, chronic 
inflammation, pulmonary foci and interstitial fibrosis, occuring as a result of excessive strain 
through augmented cardiac output and atrial stretch.13  
 
Two prior meta-analyses investigating the possible increased risk of AF in athletes have 
demonstrated equivocal findings, with odds ratios of 1.64 14 and 5.29.15 Interestingly, Ayinde 
et al. (2018)15 identified age as a significant determinant of AF risk, with younger athletes 
(below 40 years old) at greater relative risk than athletes >54 years of age. However, these 
meta-analyses excluded studies of athletes with hypertension or diabetes, which potentially 
restricts the availability of larger pooled study data for analysis. As such, this meta-analysis 
aims to establish the risk of AF in athletes and further elucidate the influence of sport type 
and cardiovascular disease (CVD) risk factors on the risk of developing AF. As the 
prevalence is relatively low, this paper aimed to perform a meta-analysis and pool multiple 










Search strategy  
 
This systematic review and meta-analysis was fully compliant with and performed according 
to the PRISMA guidelines,16 including use of the described PICOS method for the systematic 
review process. Figure 1 details the PRISMA systematic review flowchart. 
 
PubMed, MEDLINE, Science Direct, the Cochrane library and SPORTDiscus online 
databases were searched for studies reporting atrial fibrillation or atrial flutter in athletes in 
journal articles published before 2nd December 2020. Studies written in English and 
published from 1990 onwards were accepted. Key Boolean search terms were utilised to 
identify relevant studies and included; ‘atrial fibrillation’ OR ‘atrial flutter’ AND ‘athlete’, 
‘sport’, ‘endurance’ AND ‘exercise’. Where possible, corresponding study authors were 
contacted to ascertain whether non-published data was available or in the pre-print stage, and 
studies found through the systematic protocol were screened for exterior citations and their 




Screening was carried out following the exclusion of duplicate articles. Studies were initially 
excluded by title and then by abstract. Studies retained for the next step of evaluation were 
screened and included if; they reported the number of AF cases in athletes with non-athlete 
control groups, were case-control or cohort study design and the presentation of data was in 
the form of odds ratios (OR), or at least data whereby OR and confidence intervals could be 
precisely calculated.  
 
Studies were excluded in the next evaluation step if they did not include a control group and 
participants older than 18 years of age who had performed regular exercise training for at 
least a 2-year period prior to screening. For the purpose of this meta-analysis, ‘athletes’ were 
defined according to the European Society of Cardiology classification.17 Studies of athlete’s 
participating in sports other than the following were excluded; cycling, running, swimming, 
Nordic skiing, orienteering, rowing (endurance sports) and mixed sports (football, netball, 
rugby etc) as defined by Pelliccia et al (2021).17 Studies where participants had concurrent 
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diseases were excluded except for hypertension and diabetes, to exclude other confounding 
causes of AF but to include conditions common amongst the general population.18 Studies 
with these two concurrent diseases were classified and grouped for further subgroup analysis 
to determine if these diseases moderate the degree of AF prevalence and effect. Furthermore, 
studies reporting atrial flutter were included due it being a precursor to AF.  
 
For this meta-analysis, we included studies with non-exercising or recreationally exercising 
controls versus athlete populations to ascertain whether an optimal exercise duration, 
intensity or mode exists before AF manifests versus the general population. Non-athletic 
leisurely activity and physical activity participants were defined as physically active 
individuals without training regimes, athletic ambitions or participation in regular 
competition. In the literature this has been regarded as ‘leisure time physical activity’. This 
type of physical activity is generally at or below national physical activity guidelines, but not 
near the volumes or intensities seen through purposed exercise training undertaken by 
athletes. 
 
Data extraction, coding and study quality 
 
Our initial search identified 3885 citations. After all exclusions were applied, 13 studies were 
included and proceeded through to the data extraction and coding step (Figure 1). The 13 
studies included in the meta-analysis (Table 1) were coded and respective data was extracted 
including systematic processing of study details, country of registration, year of publication, 
journal impact statistics and full patient anthropometric and clinical variables, where 
available. Study data was extracted and a risk of bias analysis performed which were 
systematically screened by a second reviewer. When disputes were detected in coding or 
quality analyses, the reviewers met to discuss any conflicts, which were then resolved and 
evaluated further. 
 
AF odds ratio (OR), relative risks and raw data were extracted, and OR was calculated 
according to the presence of sample size, control and athlete AF diagnosis data. The adjusted 
status and variables adjusted for in each study are provided in the supplementary material 
(Table S1). When insufficient data was detected, best efforts were made to contact the 
relevant authors of the study or to seek additional supplementary data. If this data was not 
available, these studies were then excluded from the rest of the analyses.  
 6 
Qualitative risk of bias assessment was carried out utilising the tool from CLARITY at 
McMaster University (Evidence Partners, 2019) to ascertain the risk of bias in the cohort and 
case-control studies independently. For each of the outcomes, a number was assigned to the 
qualitative descriptor outcomes. The questions included queries surrounding the sampling of 
the population, composition and extraction of clinical data, and other factors surrounding 
blinding of participants and researchers. For case-control studies, there were 5 questions, 
whereas 8 questions were asked for cohort studies. The response to the questions was 
completed using likert integers; for example, in the question 'can we be confident in the 
assessment of the exposure', 1= definitely yes (low risk of bias) and 5 = definitely no (high 
risk of bias). The overall results of the study quality assessment composed of a single 
numerical value resulting from an average of the individual question outcomes. Further 
quantitative study quality metrics not addressed by qualitative means were computed 
alongside the meta-analysis utilising funnel plot analyses and asymmetry testing with tests of 
heterogeneity. 
 
Data analysis and research synthesis  
 
As aforementioned, raw data was extracted from studies and transformed into OR with 95% 
confidence intervals. Comprehensive Meta-Analysis (Comprehensive Meta-Analysis Version 
3, Biostat, Englewood, NJ, USA) was used to assess the reported cases of AF in athletes 
versus non-athletes. A random effects pooled analysis was performed on the 13 final studies 
due to the inter-study variability with case-control and cohort studies, and the assessment of 
AF risk in all athletes from a population, allowing conclusions of a more general level of 
inference.19 Furthermore, random effects models are typically selected when inter-study 
variability is confirmed through significant heterogeneity.20 The results of the pooled analysis 
were considered significant when a P value of <0.05 was present and the test Z statistic was 
>2. Meta-analyses were also performed independently on the following conditions; age, 
comorbid CVD risk factor inclusion, study quality and study design, to investigate pooled 
effects.  
 
Studies were inputted systematically, allowing the individual weightings of each study to be 
visible and the weighted effect on the overall effect size of the pooled analysis discerned for 
each study (Supplementary Table S2). Heterogeneity was tested alongside the pooled 
analysis to quantitatively assess the study quality and risk of bias using the chi-squared 
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technique and reported as the I2 statistic. If the I2 statistic was >40% it was considered 
significant.20 Once past this threshold, post-hoc tests such as Egger’s test (1997) were 
systematically planned to qualitatively assess the presence of funnel plot asymmetry, 
suggesting publication bias. 
 
A meta regression was run to ascertain if any effect moderator variables influenced the risk of 
developing AF in athletes versus non-athletes. The planned moderators to be assessed 
independently were; presence of diabetes, presence of hypertension, number of cases of high 





























Study and participant characteristics 
 
The meta-analysis included 13 studies (7 cohort and 6 case-control) with a pooled sample 
size of 70,478 participants, which included 63,662 controls and 6816 athletes (Online 
supplementary file). Five studies included athletes with the CVD risk factors diabetes and/or 
hypertension. Risk of bias scores, and sport types are presented in Table 1. Only two studies 
provided data on volume or average duration of exercise and both defined this by lifetime 




The initial random-effects pooled analysis demonstrated that the risk of AF was significantly 
higher in athletes than non-athletes (OR: 2.46; 95% CI 1.73-3.51, p<0.001, Z=4.97) (Figure 
2). There was significant heterogeneity amongst the studies (p<0.001, I2 = 84%). The post-




When dichotomising studies into those with and without CVD risk factors (type 2 diabetes 
mellitus and hypertension), there was no significant difference in the relative risk of AF in 
athletes with CVD risk factors versues non-athletes with CVD risk factors (OR 1.51; 95% CI 
0.90-2.54, p=0.116, Z=1.572). However, in athletes and non-athletes without CVD risk 
factors, athletes had a significantly greater relative risk of AF (OR: 3.66; 95% CI 2.28-5.88, 
p<0.001, Z=5.355). Younger athletes (OR: 3.60; 95% CI 2.09-6.29, p<0.001, Z=4.603) had a 
significantly higher relative risk of AF than older athletes (OR: 1.76; 95% CI 0.97-3.21, 
p=0.065, Z=1.845) (Figure 3) and good quality studies (OR: 2.32; 95% CI 1.62-3.32, 
p<0.001, Z=4.610) reported lower overall OR for AF in athletes than poor quality studies 
(OR: 4.80; 95% CI 1.22-18.88, p=0.025, Z=2.244) (Figure S2). Case-control studies (OR: 
4.91; 95% CI 3.48-6.93, p<0.001, Z=9.03) produced a greater relative risk of AF in athletes 
than cohort-design studies (OR: 1.26; 95% CI 1.02-1.56, p=0.035, Z=2.11). However, it was 
not possible to appropriately analyse the association of exercise intensity and AF risk due to 
insufficient data. 
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Moderator analysis  
 
There was a significant relationship between the mode of exercise and risk of AF (B=0.1259, 
p=0.0193), with mixed sport conferring a greater risk of AF compared to endurance sport 
(B=-0.5476, p=0.0204). Of the endurance sports, cycling conferred the highest risk of AF and 
Nordic skiing conferred the lowest risk (see Figure S3 for the lowest to highest risk of AF in 
endurance sports). Furthermore, younger (<55 yrs) athletes were more likely to develop AF 
(B=-0.02293, p<0.001). There was a significant relationship between study design and risk of 





























This meta-analysis aimed to quantify the risk of AF in athletes in an array of sporting 
activities, compared with non-athlete controls. The results of the analysis indicate that the 
relative risk of AF is higher in athletes than in those not exercising or performing regular, 
non-competitive physical activity. Despite the increased risk observed amongst different 
study sizes, sport types, ages and exercise modalities, there remains a lack of high-quality 
studies with consistent methodologies to quantify the maximum safest regular ‘dose’ of 
exercise before AF risk becomes significant.  
 
Firstly, our odds ratio, considering all primary studies, of 2.46 is much closer to the ‘true’ 
value as we included studies examining athletes, physically active individuals and sedentary 
populations, unlike other analyses. Additionally, the inclusion of studies involving athlete 
cohorts with common health conditions offers a more ‘real world’ estimation. Crucially, our 
research identifies a significant relationship between mode of exercise and risk of developing 
AF, with mixed sport conferring a greater risk than endurance sport. Of the studies included 
in the analysis, 3 involved Nordic skiing, with these studies representing 36% of the total 
weighting in the overall effect size. With this, it cannot be excluded that the remaining 
endurance sports included were comparatively underestimated in the analysis with Nordic 
skiing over-represented due to a greater quantity of published studies. Indeed, the observation 
that endurance sports correlate with AF is generally accepted.21 Mechanistically, Wilhelm 
(2014)13 indicate biatrial remodelling, dilation and fibrosis as crucial substrates to developing 
this pathology. However, Brugger et al. (2014)22 suggested that mechanical and electrical 
remodelling of the atria seen with chronic endurance sport is functional, and does not 
predispose individuals to a higher risk of AF. Despite this, current evidence does indicate a 
potential increase in AF risk with endurance exercise specifically.23 Seperately, the 
association of ‘mixed sports’ with an increase in AF risk is difficult to interpret due to the 
broad range of sports analysed, complicating the process of elucidating true effects from 
specific training modalities. However, training volume may be an important risk factor for 
the development of AF and merits future research.  
 
Our finding of a greater relative incidence of AF in younger athletes (OR: 3.60), echoes the 
results from Ayinde et al. (2018)15 who performed a similar meta-analysis. Additionally, 
Furlanello et al. (1998)23 examined the relationship between AF risk and sport participation 
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in elite and Olympic athletes, finding a significant prevalence amongst young (average age 
24 years old), male athletes. However, the OR in older athletes was still 1.76, and much 
higher compared to non-athletes and thus must not be ignored. Investigating the mechanistic 
underpinning of this age-dependant risk, Hoogsteen et al. (2004)24 discuss AF being triggered 
by adrenergic surges occurring during exercise in younger athletes,25 whereas older athletes 
typically experience vagally induced AF after exercise, normally from secondary autonomic 
dysfunction.26 An interesting observation is that AF risk in the general population doubles at 
each decade after 50 years of age, with a prevalence of up to 9% in 80-89 year olds.8 With 
this, the lower association of AF in older athletes compared to younger athletes has been 
previously linked to the higher rates of AF in older individuals, indepedant from physical 
activity levels.27 
 
Engagement with physical activity reduces CVD comorbidities that have been shown to 
increase the risk of AF through cumulative effects.28 In line with our inclusion criteria 
(studies where athletes train at least 3 hours a week), it is clear that once over national 
physical activity guidelines, AF prevalence begins to rise.29 However, it was not possible in 
these analyses to discern a specific duration and frequency threshold or type of exercise at 
which AF risk increased. Therefore, the current physical activity guidelines, whereby the 
benefits from the exercise outweigh the risks of any predisposition to AF, should be 
recommended.30 
 
We also aimed to ascertain AF risk in all athletes, including samples representative of those 
with CVD risk factors, which are independently associated with AF risk amongst the general 
population.31 As such, we performed sub-analyses on these CVD risk factors to understand 
their role in athlete and non-athlete AF prevelance. There was a greater prevelance of CVD in 
the non-athlete population, likely due to the cardiovascular protective role of physical 
activity; however, there was no statistically significant difference in the risk of AF in athletes 
and non-athletes with CVD risk factors. When CVD was excluded from analyses, the risk of 









One primary limitation of the present study is the possibility of residual confounding. The 
results of the included studies may be confounded in practice with studies applying different 
sets of adjusted variables. As detailed in Greenland & O’Rourke (2008)32, the present 
analysis would have benefitted from adjustment using external estimates in those studies 
which do not apply sufficient adjustment. Another issue with our study methodology arises 
around heterogeneity. Heterogeneity may develop from differences in study methodology, 
namely as our analyses sought to include studies of both case-control and cohort design, 
which account for differences in between-trial heterogeneity.33 Our analysis was positive for 
publication bias when assessed using a qualitative risk of bias tool.34 Indeed, it is possible 
that studies with a null hypotheses of a significant relationship between AF and athletes were 
not published, alongside bias in study methodologies. However, it is prudent to express 
diligence in assigning heterogeneity only to methodology, as differences in diagnostic criteria 
may change between studies, masking the ‘real’ incidence of AF.35 Importance is placed also 
in observing funnel plot asymmetry for qualitative demonstration of small studies exhibiting 
large effects, not just for bias.36 Indeed, 84% is well above an expected I2 value for a meta-
analysis, probably owing to the differences in methodological parameters in the included 
studies.20 However, we wanted to include all primary research undertaken with athletes to 
determine a more clinically relevant aspect of risk estimation for practitioners and coaching 
staff. This analysis may also be limited by the possibility of sparse-data bias in the pooled OR 
estimates, as indicated by the unconventional ORs and wide confidence limits produced by 
some studies. This is problematic as such bias can inflate the estimate of effect measures 
which should be taken into account when interpreting the findings of the present analysis.37  
 
This meta-analysis contained studies using both male and female athletes and male athletes 
alone. Due to the limited data in female athletes, it is difficult to discern the relative risk of 
AF by gender. In general, risk of AF in female athletes appears to be lower than in male 
athletes.29 38 It has been suggested that these differences in AF may be, in part, due to the 
proclivity for females to experience less atrial remodelling and electrocardiographic changes, 
alongside sex hormone differences which predispose females to higher vagal tone at rest and 
during exercise.29 However, future research is required, especially given the increased female 
participation in elite sports in recent years. Finally, due to the lack of available data, we were 




The risk of AF is greater in athletes compared to non-athletes. Mixed sports appear to confer 
a greater risk of AF. The risk of AF is relatively higher in younger athletes compared to older 
athletes, which is an association that should be investigated further (Figure 4). Large 
prospective studies are needed to address current gaps in the literature including female 
athletes and the effect of years and volume of training.  
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Table 1: Characteristics of studies included. 
Author Year Country Sample size Average age  (yrs) Sport type Study design Risk of bias* 
Aizer et al 2009 America 8448 52 Mixed & Endurancea Cohort 2 
Andersen et al 2013 Sweden 52,755 57 Nordic Skiing Cohort 2 
Baldesberger et al 2008 Switzerland 124 67 Cycling Cohort 2 
Calvo et al 2016 Spain 172 46 Mixed & Enduranceb Case-control 1 
Claessen et al 2011 Belgium 156 52 Mixed & Endurancec Case-control 2 
Elosua et al 2006 Spain 160 43 Mixed & Enduranced Case-control 1 
Karjalainen et al 1998 Finland 440 46 Orienteering Cohort 1 
Molina et al 2008 Spain 473 39 Running Cohort 1 
Mont et al 2002 Spain 216 44 Mixed & Endurancee Case-control 2 
Myrstad et al 2014 Norway 2376 69 Nordic Skiing Cohort 2 
Myrstad et al 2016 Norway 4952 69 Nordic Skiing Cohort 2 
Schreiner et al 2016 America 149 72 Swimming Case-control 3 
Van Buuren et al 2012 Germany 57 57 Handball Case-control 2 
Note: *Risk of bias: 1 = low, 2 = moderately low, 3 = moderately high, 4 = high. See online 
supplementary file for full references. a = cycling, racquet sports and swimming; b = cycling, gym, 
marathon running, swimming, team sports, tekking and other; c = basketball, cycling, diving, 
handball, horse riding, running, soccer, tennis, triathlon; d = unknown sports; e = athletics, cycling, 
running, soccer, swimming, weight lifting.
Figure Legends 
 
Figure 1. PRISMA systematic review and meta-analysis flowchart/decision tree. 
 
Figure 2: Random-effects meta-analysis of AF risk in athlete’s vs controls. 
 
Figure 3: Subgroup analysis of age and the risk of atrial fibrillation.  
 



























What is already known 
 
• Physical activity/exericse improves cardiovascular health and is associated with 
reduced morbidity and mortality. 
• Prior research suggests there is a threshold beyond which exposure to increasing 
levels of exercise is associated with an increased risk of cardiovascular disease, 
including arrhythmias (U-shaped relationship). 
• Current evidence does not allow for the identification of sport mode, which may 
predispose athletes to the greatest risk of atrial fibrillation. 
 
What are the new findings 
 
• Athletes have a significantly greater likelihood of developing atrial fibrillation 
compared to non-athlete controls. 
• Our novel comparative analysis determined that mixed sport exercise modes convey 
the greatest risk of atrial fibrillation. 
• Younger aged athletes have a greater relative risk of atrial fibrillation compared to 
older athletes; however, exercise dose parameters, including training and competition 
history, as well as potential gender differences for the risk of atrial fibrillation 
requires future research.  
 
 
 
 
 
 
 
 
 
 
 
 
